Results 261 to 265 of about 42,140 (265)

Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial

Lancet, The, 2017
Jørgen Vestbo, Alberto A Papi, Massimo Corradi   +2 more
exaly  

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

New England Journal of Medicine, 2018
Hope S Rugo, Hiroji Iwata, Seock-Ah Im
exaly  

Clinical relevance of host immunity in breast cancer: from TILs to the clinic

Nature Reviews Clinical Oncology, 2015
Peter Savas, Roberto Salgado, Carsten Denkert   +2 more
exaly  

Bevacizumab in neoadjuvant chemotherapy increases the pathological complete response rate in patients with triple‐negative breast cancer

Ca-A Cancer Journal for Clinicians, 2014
exaly  

Drug resistance in Plasmodium

Nature Reviews Microbiology, 2018
Kasturi Haldar, Souvik Bhattacharjee, Innocent Safeukui   +2 more
exaly